September 21, 2023
Republican voters were once the reasonable, critical thinking wing of the American populace. This blogger had teachers as far back as junior high telling him that everyone starts out as a liberal. No responsibilities, paired with youthful ignorance, is the gateway to liberalism. But eventually adults have jobs, own homes, have children and start voting for their interests thereof. That’s no longer the case in the U.S., as tribalism has taken precedent over critical thinking.
We’ve written a few times about Vivek Ramaswamy. He continues buying himself relevance in the 2024 GOP Presidential race, and worming his way into the hearts of GOP voters. Ramaswamy is now polling in second place behind Donald Trump in a recent CNN survey of New Hampshire voters. Florida Governor Ron DeSantis has dropped all the way to fifth place. We’re not surprised by the latter, and predicted this much in early August when DeSantis was still the undisputed second-place horse behind Trump.
It’s not all that surprising that Republican voters are flocking to Ramaswamy. He is a young, East Indian American version of Trump. Ramaswamy is a salesman like Trump. He has developed a layer of Teflon that protects him from scrutiny among his flock even when they are presented with indisputable facts about his character, past and present dealings. It’d be great for America to have young, forward-thinking individuals in positions of influence. But as is the theme on The COVID Blog® this week, we’ve reached the point of irreversible decay.
RELATED: 2024 Presidential Election determines who controls U.S. during pivotal 2025-2028 years of The Great Reset, while DeSantis, New York pass laws to facilitate their agendas (May 30, 2023)
Ramaswamy has no realistic chance of winning the Republican nomination, let alone the Presidency, in 2024. But he’s self-funded his campaign to the tune of $15 million in ill-gotten riches, and has essentially purchased a cult following among Republican voters. The GOP has the fallacious image of being against mRNA injections and “the establishment.” Yet voters are flocking to Ramaswamy, who is not only a big pharma executive himself, but also deals directly in the mRNA racket.
All politicians are nauseating and not worth sweating over. But it’s our job as journalists to present the facts about Ramaswamy herein, and allow you to use them as you wish.
Nothing in this world happens by accident
The powers-that-be (“TPTB”) groom their tools over many years. Ramaswamy is no exception. He appeared on an MSNBC Townhall for Reverend Al Sharpton during the latter’s run for the Democrat Presidential Nomination, on October 27, 2003.
Ramaswamy was 18 years old at the time. And look who else was in the audience of that same Townhall.
For those unaware, that is a 21-year-old Pete Buttigieg, the former Democrat mayor of South Bend, Indiana and the current Transportation Secretary in the Biden Administration.
We’ll forget for a moment that Ramaswamy lied and said at least twice that the first time he ever voted was in 2020 for Donald Trump. His excuse for the double lie was that he “didn’t remember” voting in 2004. Observers inundated Ramaswamy’s social media pages with links to the foregoing clip in the comments sections of their posts.
Ramaswamy, like all skilled manipulators, attempted to get out in front of this revelation by posting the clip himself via Instagram, along with his own custom sales pitch, on August 29. His worshipers ate it up. But several observers pointed out the obvious.
TPTB have been grooming this guy for 20 years.
Fake lawsuit against World Economic Forum?
Ramaswamy was listed on the World Economic Forum (WEF) “Class of 2021 Young Global Leaders” when the list was first published on March 10, 2021 (you can also see the original list here). TPTB and Ramaswamy have been scrambling to cover up this fact ever since he entered his name in the 2024 Presidential Election as the young, anti-establishment candidate.
Ramaswamy pitched a forthcoming book in response to a prominent conservative pointing out his connections to the WEF. Ramaswamy said his book, which came out in April 2023, will provide “receipts” of him telling the WEF “hell no.”
TPTB took this opportunity to further manipulate Ramaswamy’s low-hanging fruit flock.
Ramaswamy tweeted a poll, on April 18, asking his followers “should I sue the World Economic Forum” for including his name in their 2021 Young Global Leaders list. The poll garnered over 29,000 votes, with 91% in favor of Ramaswamy suing the WEF.
The next day, April 19, the New York Post published an article saying that Ramaswamy filed a lawsuit against the WEF “in a Cincinnati, Ohio, court.” The only other major and semi-major publications to report on this lawsuit were Fox News, the Epoch Times, and The Daily Caller. The latter two cited the New York Post as the primary source. Both the Post and Fox News are owned by News Corp (Rupert Murdoch).
The problem is that the World Economic Forum is headquartered in Cologny, Switzerland. Thus any alleged lawsuit would need to be brought in Switzerland, not in “a Cincinnati, Ohio court.” Obviously the Hamilton County Court in Cincinnati has no jurisdiction over a Swiss-based organization. But let’s lower our intelligence for a second and pretend the U.S. District Court for the Southern District of Ohio in Cincinnati has diversity jurisdiction over the New York and/or San Francisco offices of the WEF.
Like what you’re reading? Help keep us up and running. Please donate via Bitcoin, Ethereum, Stellar, credit/debit card, CashApp, and/or Zelle.
We searched the Public Access to Court Electronic Records (PACER) database for the Cincinnati-based Southern District of Ohio. There are no cases, active or otherwise, listed with the World Economic Forum as a Plaintiff or Defendant. The only case listed with Ramaswamy as a Plaintiff or Defendant is an ex parte petition by an investment firm called Alpine Partners (BVI). The petition is related to a case in the Supreme Court of Bermuda. It seeks to subpoena and depose Ramaswamy because he apparently swindled investors out of $1.7 billion via his big pharma rackets. More on that later.
Fox News and the Epoch Times, on August 1 and 2, respectively, published stories reporting that Ramaswamy settled the lawsuit against the WEF. The America First Policy Institute (AFPI) also acknowledged the alleged settlement. No other major media reported on the story. The COVID Blog® reached out to New York Post reporter Dana Kennedy, who wrote the original story in April, and to the editors of the New York Post, for comment on their sources for this alleged lawsuit.
Neither have responded as of publishing. It’s important to note that CBS reported that Ramaswamy and News Corp owner Rupert Murdoch met in a “get-to-know you session” in late April – coincidentally around the same time this alleged WEF lawsuit started its half-life in the news cycle. Again, News Corp owns both Fox News and the New York Post, with the latter being the origin of his alleged Ramaswamy vs. World Economic Forum lawsuit. Make of all that what you will.
The full story on how Ramaswamy got rich via pump-and-dump big pharma stock schemes
Let’s forget for a moment that Ramaswamy is against affirmative action despite taking an affirmation action fellowship for children of Indian immigrants from Paul Soros (George’s brother) in 2011. Soros is of course the number-1 boogeyman of conservatives.
We’ll also forget that Ramaswamy said he will get rid of H-1B temporary worker visas as President of the United States because they are “bad for everyone involved.” He also called the visas “indentured servitude.” Ramaswamy’s pharma company, Roivant Sciences, has had 29 H1-B visa applications approved since 2018.
Ramaswamy gets passes for his perpetual lying, flip-flopping and hypocrisy. He is also getting a pass for his big pharma stock schemes that made him millions and destroyed average investors.
Ramaswamy’s original pharma company is Bermuda-based Axovant Gene Therapies. That’s the company subject to the aforementioned Bermuda Supreme Court case. It was incorporated in February 2015. The 29-year-old Ramaswamy bought the rights to a failed Alzheimer’s drug called RVT-101 from GlaxoSmithKline (GSK) for $5 million in June 2015. The price tag was so cheap because RVT-101 had already failed four clinical trials. But if you allow the right snake oil salesman to promote the drug, it can make billions – which is exactly what happened.
Elizabeth Holmes: founder of fraudulent pharma firm Theranos sentenced to 11 years in prison (November 23, 2022)
Ramaswamy earned a spot on the cover of the September 28, 2015 issue of Forbes when he launched the biggest initial public offering (IPO) for a biotech company in history that summer. Axovant, which had only 10 employees, including Ramaswamy, his mother and his brother, raised $360 million on the “strength” of Ramaswamy selling the failed RVT-101 drug.
Axovant had a market capitalization of nearly $3 billion; and the company had only been in existence for eight months. Basically his mother, Geetha Ramaswamy, who is a doctor, cherry-picked a few positive points from one of the failed RVT-101 Stage 2 clinical trials; and Vivek used his car salesman charm to promote it. Ramaswamy successfully turned a failed drug into what many believed would be a breakthrough medicine for Alzheimer’s. They renamed the drug to Intepirdine for marketing purposes.
He took his sales pitch to CNBC’s Jim Cramer shortly after the IPO.
Axovant stock opened at $15, and closed at $29 per share on the first day of trading. Ramaswamy and his family were instant multi-millionaires. He, his family and friends sold nearly all of their stock in Axovant (cashed out) by the end of the year. That’s because they started Stage 3 clinical trials that they knew would fail in 2016-17.
When the inevitable failure of Stage 3 trials happened, Axovant stock went from its peak of $199.92 per share on September 22, 2017 to $55.04 by September 29. The stock traded at $8.88 on April 27, 2018. But it didn’t matter, as Ramaswamy and company had already cashed out. Ramaswamy made $39 million in 2015 alone, according to his 2015 (January 1 to December 31, 2015) tax return.
He made $640,000 as a hedge fund manager the year prior.
Good luck finding this stock information online. Ramaswamy knew he was running for President by late 2020. So he changed the name of his company from Axovant Gene Therapies to Sio Gene Therapies on November 11, 2020. The obvious goal was to make it harder for journalists and others to put the pieces together.
As we reported previously, Roivant, which is Ramaswamy’s main company, is under the Pfizer umbrella and specializes in mRNA gene therapies.
America loves its crooks and criminals
Conservatives continue their fallacious crusades against mRNA injections and the so-called “deep state” despite worshiping the progenitors thereof. Ramaswamy is the trifecta of vaxx zealot, Soros and WEF tool. There hasn’t been a more obvious plant by TPTB since The Great Reset commenced in March 2020. But the new MAGA Republican gravitates to these types of people. Trump is the king, and Ramaswamy is essentially a carbon copy.
Liberals will continue being shepherded to their deaths via homosexual degeneracy and vaccines. But we’ve said it many times – the Republican tribe needs idols and will follow anything said idols tell them to do. We wrote last month how Elon Musk has carved out his influence among said tribe.
RELATED: FragileX.com: Elon Musk has successfully manipulated MAGA, 4chan conservatives into obedient, duties-paying congregation on Twitter in just nine months (August 7, 2023)
Ramaswamy is appealing to the youngest of Republicans because he is a fresh face with the same stale manipulative playbook. But he can’t make up his mind as to whether he is a Trump opponent or Trump flunky.
This guy has been groomed from the time he got out of high school, and is frankly quite good at this grift. Credit must be given where it’s due.
These pump-and-dump pharma schemes are criminal. Elizabeth Holmes went to prison for doing almost the exact same thing as Ramaswamy. But the latter has the protection of Soros and the WEF; and has a greater purpose for TPTB. Further, if this blogger is the first one to notice that there is no WEF lawsuit filed in Cincinnati, then that just shows the pathetic state of U.S. journalism. Regardless, we’ll be seeing and hearing a lot more from this guy through 2024.
Stay vigilant and protect your friends and loved ones.
COVID Legal USA is your partner in fight mandatory vaccines and other COVID mandates. Follow us on Telegram. Pre-order The COVID Blog® book here.
Fight back against censorship! We are once again processing credit card donations. CLICK HERE TO DONATE VIA CREDIT OR DEBIT CARD.